Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19068InvestigationalSmall molecule
IMT-288 is under investigation in clinical trial NCT01730638 (Immunotep for Patients With Medullary Thyroid Carcinoma.).
- Formula / weight
- C64H97N19O20 · 1452.593 g/mol (avg)
- Also known as
- (4R)-5-(((1R)-1-CARBAMOYL-5-((2-((4-(2-(1H-IMIDAZOL-5-YL)ETHYLAMINO)-4-OXO-BUTANOYL)AMINO)ACETYL)AMINO)PENTYL)AMINO)-4-(((2R)-2-(((2R)-3-(4-HYDROXYPHENYL)-2-((2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAZACYCLODODEC-1-YL)ACETYL)AMINO)PROPANOYL)AMINO)-6-( · D-LYSINAMIDE, N-((4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL)ACETYL)-D-TYROSYL-N6-(N-(4-((2-(1H-IMIDAZOL-4-YL)ETHYL)AMINO)-1,4-DIOXOBUTYL)GLYCYL)-D-LYSYL-D-.ALPHA.-GLUTAMYL-N6-(N-(4-((2-(1H-IMIDAZOL-4-YL)ETHYL)AMINO)-1,4-DIOXOBUTYL)GLYCY
- Code names
- IMP-288 · IMT-288
Resolves to
Compound
Structure
InChIKey
AUULGUVUMUKNPY-OGBYROOVSA-NSMILESNC(=O)[C@@H](CCCCNC(=O)CNC(=O)CCC(=O)NCCC1=CN=CN1)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCCCNC(=O)CNC(=O)CCC(=O)NCCC1=CN=CN1)NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1What you can answer from here — as of April 23, 2025
Which companies are running trials of IMT-288, in which indications and phases, and which of those programs are still active?